Torbjörn Gräslund

22PUBLICATIONS
46CO-AUTHORS
Tumour immunologyBiomolecular modelling and designMolecular targetsPredictive and prognostic markersNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Nov 06, 2026
Selection of Anti-TIGIT Affibody Molecules Blocking the Interaction between TIGIT and CD155.

|Aug 19, 2026
Peptide Nucleic Acid Probes for Pretargeted Affibody-Mediated Delivery of Cytotoxic Payloads to HER2-Positive Carcinoma.

|Nov 20, 2025
Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents.

Sara S Rinne, Wen Yin, Ruonan Li

|Jun 13, 2025
Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture.

Vladimir Tolmachev, Anzhelika Vorobyeva, Alia Hani Binti Rosly

|Oct 17, 2024
Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts.

Jie Zhang, Sara S Rinne, Wen Yin

|Oct 02, 2024
Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model.

Soraia Pinto, Juliana Viegas, Cecília Cristelo

Pageof 4

Frequent Collaborators

16 joint publications

Anzhelika Vorobyeva

15 joint publications

Anna Orlova

13 joint publications

Vladimir Tolmachev

10 joint publications

Tianqi Xu